PDL BioPharma Q3 EPS $0.04 Misses $0.06 Estimate, Sales $4.12M Miss $5.50M Estimate
PDL BioPharma Q3 EPS $0.04 Misses $0.06 Estimate, Sales $4.12M Miss $5.50M Estimate
PDL BioPharma第三季度每股收益0.04美元未達到0.06美元預期，銷售額412萬美元未達到550萬美元預期
PDL BioPharma (NASDAQ:PDLI) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.06 by 33.33 percent. This is a 55.56 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $4.12 million which missed the analyst consensus estimate of $5.50 million by 25.18 percent. This is a 90.68 percent decrease over sales of $44.16 million the same period last year.
PDL BioPharma(納斯達克：PDLI)公佈季度每股收益為0.04美元，低於分析師普遍預期的0.06美元，降幅為33.33%。這比去年同期每股0.09美元的收益下降了55.56%。該公司公佈季度銷售額為412萬美元，低於分析師普遍預期的550萬美元，降幅為25.18%。這比去年同期4416萬美元的銷售額下降了90.68%。